ANAPTYSBIO, INC ANAB
- imsidolimab — Generalized Pustular Psoriasis Phase 3
IL-36R (2 companies · 2 programs)
Companies with an active program directed at IL-36R.
Vanda Pharmaceuticals Inc. VNDA
- imsidolimab — Generalized Pustular Psoriasis NDA Submitted